Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gabriela D. Colpo, Marion Leboyer, Robert Dantzer, Mahdukar H. Trivedi & Antonio L. Teixeira. (2018) Immune-based strategies for mood disorders: facts and challenges. Expert Review of Neurotherapeutics 18:2, pages 139-152.
Read now
Read now
Articles from other publishers (69)
Guo-Hua Wu, Que-Hui Guo, Xiao-Dong Xu, Jian-Chang Lin, Gui-Ting You, Cai-Hou Lin & Liang-Cheng Zhang. (2023) Ketamine exerts dual effects on the apoptosis of primary cultured hippocampal neurons from fetal rats in vitro. Metabolic Brain Disease 38:7, pages 2417-2426.
Crossref
Crossref
Jose Enrique de la Rubia Ortí, María Cuerda-Ballester, Claudia Emmanuela Sanchis-Sanchis, Jose María Lajara Romance, Esther Navarro-Illana & María Pilar García Pardo. (2023) Exploring the impact of ketogenic diet on multiple sclerosis: obesity, anxiety, depression, and the glutamate system. Frontiers in Nutrition 10.
Crossref
Crossref
Haimei Li, Miaomiao Zhao, Chaonan Jiang, Haoyang Zhao, Congchong Wu, Ying Li, Shiyi Zhang, Pengfeng Xu, Tingting Mou, Yi Xu & Manli Huang. (2023) Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation. Brain Sciences 13:8, pages 1223.
Crossref
Crossref
August P. M. Lullau, Emily M. W. Haga, Eivind H. Ronold & Gerard E. Dwyer. (2023) Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression. Frontiers in Neuroscience 17.
Crossref
Crossref
Kinga Sałaciak, Aleksandra Koszałka, Klaudia Lustyk, Elżbieta Żmudzka, Angelika Jagielska & Karolina Pytka. (2023) Memory impairments in rodent depression models: A link with depression theories. Progress in Neuro-Psychopharmacology and Biological Psychiatry 125, pages 110774.
Crossref
Crossref
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Maryam Shayan, Faezeh Niazi Shahraki, Yasamin hosseini, Saeideh Momtaz & Amir Hossein Abdolghaffari. (2023) IDO/Kynurenine; novel insight for treatment of inflammatory diseases. Cytokine 166, pages 156206.
Crossref
Crossref
Attila Tóth, Katalin Sviatkó, László Détári & Tünde Hajnik. (2023) Ketamine affects homeostatic sleep regulation in the absence of the circadian sleep-regulating component in freely moving rats. Pharmacology Biochemistry and Behavior 225, pages 173556.
Crossref
Crossref
Jenessa N. Johnston, Maximillian S. Greenwald, Ioline D. Henter, Christoph Kraus, Anahit Mkrtchian, Neil G. Clark, Lawrence T. Park, Philip Gold, Carlos A. ZarateJrJr & Bashkim Kadriu. (2023) Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile. Drug Discovery Today 28:4, pages 103518.
Crossref
Crossref
Hans O. Kalkman. (2023) Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles. Biomedicines 11:3, pages 806.
Crossref
Crossref
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, Jessica R. Gilbert, Ioline D. Henter & Carlos A. ZarateJr.Jr.. (2023) Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment. Neuropharmacology 226, pages 109422.
Crossref
Crossref
Michael R. Irwin, Chloe C. Boyle, Joshua H. Cho, Dominique Piber, Elizabeth C. Breen, Nina Sadeghi, Daisy Castillo, Michael Smith, Naomi I. Eisenberger & Richard Olmstead. (2023) Sleep and Healthy Aging Research on Depression (SHARE-D) randomized controlled trial: Protocol overview of an experimental model of depression with insomnia, inflammation, and affect mechanisms in older adults. Brain, Behavior, & Immunity - Health 28, pages 100601.
Crossref
Crossref
Yu-Jung Cheng, Chieh-Hsin Lin & Hsien-Yuan Lane. (2023) Ketamine, benzoate, and sarcosine for treating depression. Neuropharmacology 223, pages 109351.
Crossref
Crossref
Shvetank Bhatt, Thangaraj Devadoss, Niraj Kumar Jha, Moushumi Baidya, Gaurav Gupta, Dinesh Kumar Chellappan, Sachin Kumar Singh & Kamal Dua. (2022) Targeting inflammation: a potential approach for the treatment of depression. Metabolic Brain Disease 38:1, pages 45-59.
Crossref
Crossref
Brandon Richardson, Andrew MacPherson & Francis Bambico. (2022) Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments. Brain, Behavior, & Immunity - Health 26, pages 100554.
Crossref
Crossref
Tarapati Rani, Tapan Behl, Neelam Sharma, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Abdulkarim M. Meraya, Saurabh Bhatia & Simona Gabriela Bungau. (2022) Exploring the role of biologics in depression. Cellular Signalling 98, pages 110409.
Crossref
Crossref
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, Manon Lebel & Caroline Menard. (2021) Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders. European Journal of Neuroscience 55:9-10, pages 2851-2894.
Crossref
Crossref
Steven J. Lamontagne, Elizabeth D. Ballard & Carlos A. ZarateJr.Jr.. (2022) Effects of stress on endophenotypes of suicide across species: A role for ketamine in risk mitigation. Neurobiology of Stress 18, pages 100450.
Crossref
Crossref
Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch & Kevin W. Morin. (2022) Optimized Clinical Strategies for Treatment-Resistant Depression: Integrating Ketamine Protocols with Trauma- and Attachment-Informed Psychotherapy. Psych 4:1, pages 119-141.
Crossref
Crossref
Flurin Cathomas, Laura Bevilacqua, Aarthi Ramakrishnan, Hope Kronman, Sara Costi, Molly Schneider, Kenny L. Chan, Long Li, Eric J. Nestler, Li Shen, Dennis S. Charney, Scott J. Russo & James W. Murrough. (2022) Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression. Translational Psychiatry 12:1.
Crossref
Crossref
Dominik K. E. Beyer, Annika Mattukat & Nadja Freund. (2021) Prefrontal dopamine D1 receptor manipulation influences anxiety behavior and induces neuroinflammation within the hippocampus. International Journal of Bipolar Disorders 9:1.
Crossref
Crossref
Naghmeh Nikkheslat. (2021) Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain, Behavior, & Immunity - Health 18, pages 100383.
Crossref
Crossref
Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch & Kevin W. Morin. (2021) An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression. Frontiers in Psychiatry 12.
Crossref
Crossref
Johanna Louise Keeler, Janet Treasure, Mario F. Juruena, Carol Kan & Hubertus Himmerich. (2021) Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 13:11, pages 4158.
Crossref
Crossref
Yufeng Jia, Xiao Zhuang, Yi Zhang, Ming Zhao, Nuo Chen, Wen Li, Faliang Zhu, Chun Guo, Yan Li, Qun Wang, Yuan Li & Lining Zhang. (2021) The brain targeted delivery of programmed cell death 4 specific siRNA protects mice from CRS-induced depressive behavior. Cell Death & Disease 12:11.
Crossref
Crossref
Jialing Zhang, Jiping Zhang, Zhinan Zhang, Yu Zheng, Zheng Zhong, Zengyu Yao, Xiaowen Cai, Lixing Lao, Yong Huang & Shanshan Qu. (2021)
Dopaminergic signaling in prefrontal cortex contributes to the antidepressant effect of electroacupuncture: An
iTRAQ‐based
proteomics analysis in a rat model of
CUMS
. The Anatomical Record 304:11, pages 2454-2469.
Crossref
Crossref
Eric S. Schwenk, Basant Pradhan, Rohit Nalamasu, Lucas Stolle, Irving W. Wainer, Michael Cirullo, Alexander Olson, Joseph V. Pergolizzi, Marc C. Torjman & Eugene R. Viscusi. (2021) Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity. Current Pain and Headache Reports 25:9.
Crossref
Crossref
Emma Kopra, Valeria Mondelli, Carmine Pariante & Naghmeh Nikkheslat. (2021) Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review. Journal of Psychopharmacology 35:8, pages 934-945.
Crossref
Crossref
Ja Wook Koo & Eric S. Wohleb. (2021) How Stress Shapes Neuroimmune Function: Implications for the Neurobiology of Psychiatric Disorders. Biological Psychiatry 90:2, pages 74-84.
Crossref
Crossref
Nan Zhang, Lihua Yao, Peilin Wang & Zhongchun Liu. (2021) Immunoregulation and antidepressant effect of ketamine. Translational Neuroscience 12:1, pages 218-236.
Crossref
Crossref
Thelma Beatriz González-Castro, Carlos Alfonso Tovilla-Zárate, Isela Esther Juárez-Rojop, María Lilia López-Narváez, Nonanzit Pérez-Hernández, José Manuel Rodríguez-Pérez & Alma Delia Genis-Mendoza. (2021) The role of gene polymorphisms, and analysis of peripheral and central levels of interleukins in suicidal behavior: A systematic review. Journal of Affective Disorders 279, pages 398-411.
Crossref
Crossref
Anees Bahji, Gustavo H. Vazquez, Elisa M. Brietzke & Carlos A. Zarate. 2021. Ketamine for Treatment-Resistant Depression. Ketamine for Treatment-Resistant Depression
117
129
.
Kangyu Jin, Jing Lu, Zhebin Yu, Zhe Shen, Haimei Li, Tingting Mou, Yi Xu & Manli Huang. (2020) Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression. Journal of Affective Disorders 277, pages 204-211.
Crossref
Crossref
Chen-Chen Li, Ning Jiang, Long Gan, Meng-Jun Zhao, Qi Chang, Xin-Min Liu & Rui-Le Pan. (2020) Peripheral and cerebral abnormalities of the tryptophan metabolism in the depression-like rats induced by chronic unpredicted mild stress. Neurochemistry International 138, pages 104771.
Crossref
Crossref
Yanni Zhan, Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Xiaofeng Lan, Xiurong Deng, Yan Xu, Bin Zhang & Yuping Ning. (2020) Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder. Translational Psychiatry 10:1.
Crossref
Crossref
Domenico De Berardis, Carmine Tomasetti, Maurizio Pompili, Gianluca Serafini, Federica Vellante, Michele Fornaro, Alessandro Valchera, Giampaolo Perna, Umberto Volpe, Giovanni Martinotti, Silvia Fraticelli, Massimo Di Giannantonio, Yong-Ku Kim & Laura Orsolini. (2020) An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine. Current Topics in Medicinal Chemistry 20:7, pages 554-584.
Crossref
Crossref
Fatma Tannich, Asma Tlili, Coralie Pintard, Amina Chniguir, Bruno Eto, Pham My-Chan Dang, Ouajdi Souilem & Jamel El-Benna. (2019) Activation of the phagocyte NADPH oxidase/NOX2 and myeloperoxidase in the mouse brain during pilocarpine-induced temporal lobe epilepsy and inhibition by ketamine. Inflammopharmacology 28:2, pages 487-497.
Crossref
Crossref
Michael Roman & Michael R. Irwin. (2020) Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far. Brain, Behavior, and Immunity 83, pages 7-21.
Crossref
Crossref
Matjaž Stenovec, Mićo Božić, Samo Pirnat & Robert Zorec. (2019) Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles. Neurochemical Research 45:1, pages 109-121.
Crossref
Crossref
Naoyuki Hironaka. 2020. Ketamine. Ketamine
89
103
.
Oliver D. Robertson, Nieves G. Coronado, Rickinder Sethi, Michael Berk & Seetal Dodd. (2019) Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Intervention in Psychiatry 13:5, pages 1032-1049.
Crossref
Crossref
Jia-Hui Ma, Sai-Ying Wang, He-Ya Yu, Dan-Yang Li, Shi-Chao Luo, Shan-Shan Zheng, Li-Fei Wan & Kai-Ming Duan. (2019) Prophylactic use of ketamine reduces postpartum depression in Chinese women undergoing cesarean section✰. Psychiatry Research 279, pages 252-258.
Crossref
Crossref
Hans O. Kalkman. (2019) Novel Treatment Targets Based on Insights in the Etiology of Depression: Role of IL-6 Trans-Signaling and Stress-Induced Elevation of Glutamate and ATP. Pharmaceuticals 12:3, pages 113.
Crossref
Crossref
Neil R. Smalheiser. (2019) Ketamine: A Neglected Therapy for Alzheimer Disease. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Manoj P. Dandekar, Ashwini Saxena, Giselli Scaini, Joo Hyun Shin, Agata Migut, Vijayasree Vayalanellore Giridharan, Yuzhi Zhou, Tatiana Barichello, Jair C. Soares, Joao Quevedo & Albert J. Fenoy. (2018) Medial Forebrain Bundle Deep Brain Stimulation Reverses Anhedonic-Like Behavior in a Chronic Model of Depression: Importance of BDNF and Inflammatory Cytokines. Molecular Neurobiology 56:6, pages 4364-4380.
Crossref
Crossref
Jialing Zhang, Zhinan Zhang, Jiping Zhang, Zheng Zhong, Zengyu Yao, Shanshan Qu & Yong Huang. (2019) Electroacupuncture Improves Antidepressant Effects in CUMS Rats by Protecting Hippocampal Synapse and Mitochondrion: An Ultrastructural and iTRAQ Proteomic Study. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-11.
Crossref
Crossref
Jun Shen, Chujie Qu, Linling Xu, Huimin Sun & Junjian Zhang. (2018) Resveratrol exerts a protective effect in chronic unpredictable mild stress–induced depressive-like behavior: involvement of the AKT/GSK3β signaling pathway in hippocampus. Psychopharmacology 236:2, pages 591-602.
Crossref
Crossref
Jennifer R. Rainville & Georgia E. Hodes. (2018) Inflaming sex differences in mood disorders. Neuropsychopharmacology 44:1, pages 184-199.
Crossref
Crossref
Becky Inkster, Gwyneth Zai, Gemma Lewis & Kamilla W. Miskowiak. (2018) GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?. Translational Psychiatry 8:1.
Crossref
Crossref
Jianguo Li, Luwen Hou, Cui Wang, Xueyang Jia, Xuemei Qin & Changxin Wu. (2018) Short Term Intrarectal Administration of Sodium Propionate Induces Antidepressant-Like Effects in Rats Exposed to Chronic Unpredictable Mild Stress. Frontiers in Psychiatry 9.
Crossref
Crossref
Domenico De Berardis, Michele Fornaro, Alessandro Valchera, Marilde Cavuto, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellante, Laura Orsolini, Annastasia Fiengo, Antonio Ventriglio, Kim Yong-Ku, Giovanni Martinotti, Massimo Di Giannantonio & Carmine Tomasetti. (2018) Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors. International Journal of Molecular Sciences 19:10, pages 2888.
Crossref
Crossref
Zhijian Wang, Shengbing Liu, Weiwei Pan, Yanjun Guo & Zhongfei Shen. (2018) Bafilomycin A1 alleviates depression‑like symptoms in chronic unpredictable mild stress rats. Molecular Medicine Reports.
Crossref
Crossref
Yashika Bansal, Raghunath Singh, Priyanka Saroj, Rupinder Kaur Sodhi & Anurag Kuhad. (2018) Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression. Toxicology and Applied Pharmacology 355, pages 257-268.
Crossref
Crossref
Cristy Phillips & Atoossa Fahimi. (2018) Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression. Frontiers in Neuroscience 12.
Crossref
Crossref
Kai-Ming Duan, Jia-Hui Ma, Sai-Ying Wang, ZhengDong Huang, YingYong Zhou & HeYa Yu. (2018) The role of tryptophan metabolism in postpartum depression. Metabolic Brain Disease 33:3, pages 647-660.
Crossref
Crossref
Carola Rong, Caroline Park, Joshua Rosenblat, Mehala Subramaniapillai, Hannah Zuckerman, Dominika Fus, Yena Lee, Zihang Pan, Elisa Brietzke, Rodrigo Mansur, Danielle Cha, Leanna Lui & Roger McIntyre. (2018) Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder. International Journal of Environmental Research and Public Health 15:4, pages 771.
Crossref
Crossref
Amanda L. Maciel, Helena M. Abelaira, Airam B. de Moura, Thays G. de Souza, Thayse Rosa, Danyela Matos, Talita Tuon, Leandro Garbossa, Ana Paula Strassi, Maria Eduarda Fileti, Mariana P. Goldim, Khiany Mathias, Fabricia Petronilho, João Quevedo & Gislaine Z. Réus. (2018) Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events. Brain Research Bulletin 137, pages 204-216.
Crossref
Crossref
Joshua Holmes, Frances Corrigan & Mark R. Hutchinson. 2018. Inflammation and Immunity in Depression. Inflammation and Immunity in Depression
223
240
.
Chi‑Jung HuangFa‑Kung LeeShao‑Kuan ChenChih‑Cheng ChienSheng‑Tang WuYen‑Chieh Wang. (2017) Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis. International Journal of Molecular Medicine.
Crossref
Crossref
Yu-Hao Xu, Ming Yu, Hong Wei, Shun Yao, Si-Yuan Chen, Xiao-Lan Zhu & Yue-Feng Li. (2017) Fibroblast growth factor 22 is a novel modulator of depression through interleukin-1β. CNS Neuroscience & Therapeutics 23:11, pages 907-916.
Crossref
Crossref
Yuefeng Li, Xiaolan Zhu, Shenghong Ju, Jinchuan Yan, Dongqing Wang, Yan Zhu & Fengchao Zang. (2017) Detection of volume alterations in hippocampal subfields of rats under chronic unpredictable mild stress using 7T MRI: A follow-up study. Journal of Magnetic Resonance Imaging 46:5, pages 1456-1463.
Crossref
Crossref
Yuefeng Li, Jinchuan Yan, Xiaolan Zhu, Yan Zhu, Shun Yao, Yuhao Xu & Shenghong Ju. (2017) Dilated Virchow–Robin spaces in the hippocampus impact behaviors and effects of anti-depressant treatment in model of depressed rats. Journal of Affective Disorders 219, pages 17-24.
Crossref
Crossref
Amanda Eskelund, Yan Li, David P. Budac, Heidi K. M?ller, Maria Gulinello, Connie Sanchez & Gregers Wegener. (2017) Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior. Journal of Neurochemistry 142:1, pages 118-131.
Crossref
Crossref
Sally A. Abuelezz, Nevien Hendawy & Yosra Magdy. (2016) Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats. Journal of Neuroimmune Pharmacology 12:2, pages 277-291.
Crossref
Crossref
Alexandra K. Brooks, Tiffany M. Janda, Marcus A. Lawson, Jennifer L. Rytych, Robin A. Smith, Cecilia Ocampo-Solis & Robert H. McCusker. (2017) Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases. Brain, Behavior, and Immunity 62, pages 219-229.
Crossref
Crossref
Yanning Li, Ruipeng Shen, Gehua Wen, Runtao Ding, Ao Du, Jichuan Zhou, Zhibin Dong, Xinghua Ren, Hui Yao, Rui Zhao, Guohua Zhang, Yan Lu & Xu Wu. (2017) Effects of Ketamine on Levels of Inflammatory Cytokines IL-6, IL-1?, and TNF-? in the Hippocampus of Mice Following Acute or Chronic Administration. Frontiers in Pharmacology 8.
Crossref
Crossref
R.D. Idell, G. Florova, A.A. Komissarov, S. Shetty, R.B.S. Girard & S. Idell. (2017) The fibrinolytic system: A new target for treatment of depression with psychedelics. Medical Hypotheses 100, pages 46-53.
Crossref
Crossref
Chang-Hong Wang, Jing-Yang Gu, Xiao-Li Zhang, Jiao Dong, Jun Yang, Ying-Li Zhang, Qiu-Fen Ning, Xiao-Wen Shan & Yan Li. (2016) Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model. Behavioral and Brain Functions 12:1.
Crossref
Crossref
Min Li, Huanzhang Shao, Xia Zhang & Bingyu Qin. (2016) Hesperidin Alleviates Lipopolysaccharide-Induced Neuroinflammation in Mice by Promoting the miRNA-132 Pathway. Inflammation 39:5, pages 1681-1689.
Crossref
Crossref
Guang-Fen Zhang, Jing Wang, Jin-Feng Han, Jie Guo, Ze-Min Xie, Wei Pan, Jian-Jun Yang & Kang-Jian Sun. (2016) Acute single dose of ketamine relieves mechanical allodynia and consequent depression-like behaviors in a rat model. Neuroscience Letters 631, pages 7-12.
Crossref
Crossref